| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Risk and the pregnant body.
|
Hastings Cent Rep
|
2009
|
4.63
|
|
2
|
Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis.
|
Ann Intern Med
|
2011
|
3.52
|
|
3
|
Oophorectomy vs ovarian conservation with hysterectomy: cardiovascular disease, hip fracture, and cancer in the Women's Health Initiative Observational Study.
|
Arch Intern Med
|
2011
|
3.00
|
|
4
|
Cost utility of prenatal diagnosis and the risk-based threshold.
|
Lancet
|
2004
|
3.00
|
|
5
|
Risks, values, and decision making surrounding pregnancy.
|
Obstet Gynecol
|
2007
|
2.11
|
|
6
|
Mode of delivery: toward responsible inclusion of patient preferences.
|
Obstet Gynecol
|
2008
|
1.57
|
|
7
|
Hysterectomy versus expanded medical treatment for abnormal uterine bleeding: clinical outcomes in the medicine or surgery trial.
|
Obstet Gynecol
|
2004
|
1.52
|
|
8
|
Recruitment strategies for minority participation: challenges and cost lessons from the POWER interview.
|
Ethn Dis
|
2005
|
1.52
|
|
9
|
Day-to-Day Impact of Vaginal Aging questionnaire: a multidimensional measure of the impact of vaginal symptoms on functioning and well-being in postmenopausal women.
|
Menopause
|
2015
|
1.47
|
|
10
|
Decrease in urinary incontinence management costs in women enrolled in a clinical trial of weight loss to treat urinary incontinence.
|
Obstet Gynecol
|
2012
|
1.45
|
|
11
|
A community-based study of acne-related health preferences in adolescents.
|
Arch Dermatol
|
2008
|
1.44
|
|
12
|
Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction.
|
Cancer
|
2005
|
1.43
|
|
13
|
Racial and ethnic disparities in benign gynecologic conditions and associated surgeries.
|
Am J Obstet Gynecol
|
2010
|
1.32
|
|
14
|
Sexual function and aging in racially and ethnically diverse women.
|
J Am Geriatr Soc
|
2009
|
1.11
|
|
15
|
Quality and equality in obstetric care: racial and ethnic differences in caesarean section delivery rates.
|
Paediatr Perinat Epidemiol
|
2009
|
1.08
|
|
16
|
"I'm going to die of something anyway": women's perceptions of tamoxifen for breast cancer risk reduction.
|
Ethn Dis
|
2005
|
1.04
|
|
17
|
What parents want to know about the storage and use of residual newborn bloodspots.
|
Am J Med Genet A
|
2014
|
1.04
|
|
18
|
Obstetricians' attitudes and beliefs regarding umbilical cord clamping.
|
J Matern Fetal Neonatal Med
|
2013
|
0.97
|
|
19
|
Social and familial context of prenatal genetic testing decisions: are there racial/ethnic differences?
|
Am J Med Genet C Semin Med Genet
|
2003
|
0.94
|
|
20
|
Patient preferences for different severities of and treatments for overactive bladder.
|
Female Pelvic Med Reconstr Surg
|
2011
|
0.93
|
|
21
|
Medicine or Surgery (Ms): a randomized clinical trial comparing hysterectomy and medical treatment in premenopausal women with abnormal uterine bleeding.
|
Control Clin Trials
|
2004
|
0.92
|
|
22
|
Assessment of demand for prenatal diagnostic testing using willingness to pay.
|
Obstet Gynecol
|
2004
|
0.91
|
|
23
|
Finding autonomy in birth.
|
Bioethics
|
2009
|
0.91
|
|
24
|
The Association of Expanded Access to a Collaborative Midwifery and Laborist Model With Cesarean Delivery Rates.
|
Obstet Gynecol
|
2015
|
0.90
|
|
25
|
Effects of changes in prenatal aneuploidy screening policies in an integrated health care system.
|
Obstet Gynecol
|
2013
|
0.90
|
|
26
|
Management of the low-grade abnormal Pap smear: What are women's preferences?
|
J Fam Pract
|
2002
|
0.90
|
|
27
|
Perceived risk of prenatal diagnostic procedure-related miscarriage and Down syndrome among pregnant women.
|
Am J Obstet Gynecol
|
2008
|
0.89
|
|
28
|
Surveillance after treatment for cervical intraepithelial neoplasia: outcomes, costs, and cost-effectiveness.
|
Obstet Gynecol
|
2010
|
0.89
|
|
29
|
Development and validation of a sexual functioning measure for use in diverse women's health outcome studies.
|
Am J Obstet Gynecol
|
2008
|
0.89
|
|
30
|
Influence of patient preferences on the cost-effectiveness of screening for lynch syndrome.
|
J Oncol Pract
|
2012
|
0.87
|
|
31
|
Understanding risk, patient and provider preferences, and obstetrical decision making: approach to delivery after cesarean.
|
Semin Perinatol
|
2010
|
0.86
|
|
32
|
Decision making for primary cesarean delivery: the role of patient and provider preferences.
|
Semin Perinatol
|
2012
|
0.85
|
|
33
|
Comparison and correlates of three preference-based health-related quality-of-life measures among overweight and obese women with urinary incontinence.
|
Qual Life Res
|
2011
|
0.85
|
|
34
|
Abortion attitudes of pregnant women in prenatal care.
|
Am J Obstet Gynecol
|
2005
|
0.84
|
|
35
|
Factors associated with undergoing bilateral salpingo-oophorectomy at the time of hysterectomy for benign conditions.
|
Obstet Gynecol
|
2009
|
0.84
|
|
36
|
Conservative versus aggressive follow up of mildly abnormal Pap smears: testing for process utility.
|
Health Econ
|
2003
|
0.83
|
|
37
|
Randomized trial of medical treatment versus hysterectomy for abnormal uterine bleeding: resource use in the Medicine or Surgery (Ms) trial.
|
Am J Obstet Gynecol
|
2006
|
0.83
|
|
38
|
Identifying a "range of reasonable options" for cervical cancer screening.
|
Obstet Gynecol
|
2015
|
0.83
|
|
39
|
Long-Term Outcomes of the Total or Supracervical Hysterectomy (TOSH) Trial.
|
Female Pelvic Med Reconstr Surg
|
2010
|
0.82
|
|
40
|
Variation in Women's Understanding of Prenatal Testing.
|
Obstet Gynecol
|
2015
|
0.82
|
|
41
|
Nuchal translucency and first trimester biochemical markers for down syndrome screening: a cost-effectiveness analysis.
|
Am J Obstet Gynecol
|
2002
|
0.82
|
|
42
|
Association between vaginal birth after cesarean delivery and primary cesarean delivery rates.
|
Obstet Gynecol
|
2013
|
0.81
|
|
43
|
The day-to-day impact of urogenital aging: perspectives from racially/ethnically diverse women.
|
J Gen Intern Med
|
2009
|
0.81
|
|
44
|
Preferences for genetic testing to identify hereditary colorectal cancer: perspectives of high-risk patients, community members, and clinicians.
|
J Cancer Educ
|
2012
|
0.81
|
|
45
|
Prevalence and use of complementary health approaches among women with chronic pelvic pain in a prospective cohort study.
|
Pain Med
|
2014
|
0.81
|
|
46
|
Race/Ethnicity and pregnancy decision making: the role of fatalism and subjective social standing.
|
J Womens Health (Larchmt)
|
2010
|
0.81
|
|
47
|
Attitudes toward birth spacing among low-income, postpartum women: a qualitative analysis.
|
Matern Child Health J
|
2012
|
0.80
|
|
48
|
Predictors of postpartum sexual activity and function in a diverse population of women.
|
J Midwifery Womens Health
|
2013
|
0.80
|
|
49
|
Oophorectomy in premenopausal women: health-related quality of life and sexual functioning.
|
Obstet Gynecol
|
2007
|
0.80
|
|
50
|
Tamoxifen for breast cancer risk reduction: impact of alternative approaches to quality-of-life adjustment on cost-effectiveness analysis.
|
Med Care
|
2008
|
0.79
|
|
51
|
Chemoprevention: drug pricing and mortality: the case of tamoxifen.
|
Cancer
|
2006
|
0.79
|
|
52
|
Predictors of hysterectomy in women with common pelvic problems: a uterine survival analysis.
|
J Am Coll Surg
|
2007
|
0.79
|
|
53
|
Predictors of impact of vaginal symptoms in postmenopausal women.
|
Menopause
|
2016
|
0.78
|
|
54
|
Symptom resolution after hysterectomy and alternative treatments for chronic pelvic pain: does depression make a difference?
|
Am J Obstet Gynecol
|
2011
|
0.78
|
|
55
|
Prevalence and incidence of urinary incontinence in a diverse population of women with noncancerous gynecologic conditions.
|
Female Pelvic Med Reconstr Surg
|
2010
|
0.78
|
|
56
|
Influence of patient preferences on the cost-effectiveness of screening for Lynch syndrome.
|
Am J Manag Care
|
2012
|
0.78
|
|
57
|
Perceptions of prenatal testing for birth defects among rural Latinas.
|
Matern Child Health J
|
2007
|
0.78
|
|
58
|
Recurrence of Preterm Birth and Early Term Birth.
|
Obstet Gynecol
|
2016
|
0.78
|
|
59
|
Prenatal Testing in the Genomic Age: Clinical Outcomes, Quality of Life, and Costs.
|
Obstet Gynecol
|
2015
|
0.77
|
|
60
|
Patient willingness to participate in a clinical trial with preimplantation genetic diagnosis.
|
Fertil Steril
|
2007
|
0.77
|
|
61
|
Resource use for total and supracervical hysterectomies: results of a randomized trial.
|
Obstet Gynecol
|
2004
|
0.76
|
|
62
|
Patient and provider attitudes toward screening for Down syndrome in a Latin American country where abortion is illegal.
|
Int J Gynaecol Obstet
|
2011
|
0.76
|
|
63
|
The effect of weight loss on changes in health-related quality of life among overweight and obese women with urinary incontinence.
|
Qual Life Res
|
2011
|
0.76
|
|
64
|
Reproductive Travel of Intended Parents for Delivery of Gestational Carrier Pregnancies.
|
Obstet Gynecol
|
2020
|
0.75
|
|
65
|
Sleep problems among women with noncancerous gynecologic conditions.
|
J Psychosom Obstet Gynaecol
|
2014
|
0.75
|
|
66
|
Support and self-efficacy among Latino and White parents of children with ID.
|
Am J Intellect Dev Disabil
|
2015
|
0.75
|
|
67
|
Human Immunodeficiency Virus (HIV)- and Non-HIV-Associated Immunosuppression and Risk of Cervical Neoplasia.
|
Obstet Gynecol
|
2017
|
0.75
|
|
68
|
The effect of ultralow-dose transdermal estradiol on sexual function in postmenopausal women.
|
Am J Obstet Gynecol
|
2008
|
0.75
|
|
69
|
Success of uterus-preserving treatments for abnormal uterine bleeding, chronic pelvic pain, and symptomatic fibroids: age and bridges to menopause.
|
Am J Obstet Gynecol
|
2011
|
0.75
|
|
70
|
Evaluation of the Sexual Desire Relationship Distress Scale (SDRDS) in women with hypoactive sexual desire disorder.
|
J Sex Med
|
2012
|
0.75
|